Recent Developments in the Use of Baculovirus Expression Vectors

Area of Science:

• Biotechnology
• Molecular Biology
• Virology

Background:

• The baculovirus expression vector system (BEVS) has been a cornerstone for recombinant protein production for over 35 years.
• Initial methods for recombinant virus selection were cumbersome, but advancements have broadened its accessibility and applications.
• Despite its utility, challenges remain, particularly in expressing difficult protein classes like membrane-bound or secreted proteins.

Purpose of the Study:

• To review recent advancements in the baculovirus expression vector system.
• To highlight improvements with potential for generic application in recombinant protein synthesis.
• To summarize parallel developments in host cell engineering and culture conditions for enhanced protein production.

Main Methods:

• Review of recent scientific literature on baculovirus expression systems.
• Analysis of advancements in recombinant virus selection and vector design.
• Examination of host cell modifications and optimization of culture conditions.

Main Results:

• The baculovirus expression vector system has expanded to include complex molecule expression, virus-like particle production for gene therapy, and vaccine development.
• Several products derived from this system are now commercially available for human and veterinary use.
• Despite successes, challenges persist in producing certain protein types, necessitating further system improvements.

Conclusions:

• The baculovirus expression vector system continues to evolve, offering significant potential for therapeutic protein production.
• Future advancements lie in refining vector design, optimizing host cells, and improving culture conditions.
• Overcoming current limitations will further enhance the system's utility for challenging recombinant protein targets.